BridgeMD
New treatment option for Abdominal Hysterectomy
Official title The Effect of Two Different Analgesic Techniques on Postoperative Recovery Quality
ClinicalTrials.gov ID: NCT06766994
What this study is testing
- What it's testing
- Hysterectomy is one of the most frequently performed surgical procedures after Caesarean section in many countries of the world and involves the removal of the uterine corpus with or without the cervix (total hysterectomy) or without the cervix (subtotal or supracervical hysterectomy) to treat a range of gynecological problems. Hysterectomy is performed abdominally, vaginally with laparotomy, or using minimally invasive techniques (laparoscopy, robotic surgery).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65, women only
You may be able to join if
- Patients scheduled to undergo abdominal hysterectomy surgery under general anesthesia
- Ages between 18-65
- American Society of Anesthesiologists classification I-II
You likely can't join if
- Patients with a BMI ≥ 35,
- Patients with allergies to the drugs to be used in the study,
- Patients with severe liver or kidney failure,
- Patients with a history of long-term use of nonsteroidal anti-inflammatory and opioid analgesics,
- Patients with a history of gastrointestinal bleeding, peptic ulcers or inflammatory bowel disease,
- Patients with a history of diabetes or other neuropathic diseases,
See the full eligibility criteria
- Patients scheduled to undergo abdominal hysterectomy surgery under general anesthesia
- Ages between 18-65
- American Society of Anesthesiologists classification I-II
- Patients with a BMI ≥ 35,
- Patients with allergies to the drugs to be used in the study,
- Patients with severe liver or kidney failure,
- Patients with a history of long-term use of nonsteroidal anti-inflammatory and opioid analgesics,
- Patients with a history of gastrointestinal bleeding, peptic ulcers or inflammatory bowel disease,
- Patients with a history of diabetes or other neuropathic diseases,
- Patients who developed atrioventricular block and bradycardia before surgery,
- Patients with a history of serious underlying respiratory disease and psychiatric diseases,
- Patients with ASA stage 3 or higher,
- Patients who cannot use a patient-controlled analgesia (PCA) device,
- Patients who need to stop the drug used in the study during surgery for any reason,
- Patients who do not consent to participate in the study
The study team makes the final eligibility decision.
Where it's taking place
- Erzurum, Yakutiye, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Erzurum, Yakutiye, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.